Forensic · ICCM

IceCure Medical Ltd.

12
MODERATE
12/100
1 signal from 0 red flags, 0 cyber, 1 dilution event

Top signals

Atm Offering Active
424B5 ATM offering prospectus in the last 6 months (active dilution).
+12

Bear case preview · free

IceCure Medical's moderate risk profile is primarily driven by an active ATM offering, which enables ongoing shareholder dilution at management's discretion without requiring separate stockholder approvals. This capital-raising mechanism, while common among smaller biomedical firms, allows the company to access market liquidity on an opportunistic basis—a signal that near-term cash runway may be constrained relative to operational burn. Watch the next 6-8 quarterly filings for the cumulative share count trajectory and any material changes to cash burn rates or clinical trial enrollment metrics that would justify the continued ATM drawdowns.

↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.

What we checked

✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
1 S-3 + 424B5 filing
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9 · one-time · emailed in under a minute

The full bear case on ICCM

Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.

No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.

Not ready to buy? Get a free preview by email instead

We'll email you the top 3 signals on ICCM + a discount code for the full report. No subscription, no spam.

Share this score: X / Twitter

Score another ticker

Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.